NCT00595426

A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery

A Phase 2b, Double-Blind, Double-Dummy, Randomized, Parallel Group Study to Evaluate the Safety and Efficacy of Twice Daily Dosing and Once Daily Dosing of YM150 in Subjects Undergoing Primary Elective Knee Arthroplasty

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 685 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the safety and efficacy of twice daily dosing and once daily dosing of YM150 in subjects undergoing primary elective knee replacement surgery

Conditions

• Arthroplasty, Replacement, Knee

Interventions

Type	Name	Description
DRUG	YM150	Oral
DRUG	Warfarin	Oral

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-05-01
• Completion: 2009-05-01
• First posted: 2008-01-16
• Last updated: 2013-03-25

Locations

54 sites across 2 countries: United States, Canada